Compare Cytokinetics Inc (CYTK) vs Banco Santander SA (SAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Banco Santander SA — how do they compare? Cytokinetics Inc trades at $77.39 (market cap $10.63B), while Banco Santander SA trades at $14.88 (market cap $211.63B). The key difference: Banco Santander SA is far larger — about 19.9× Cytokinetics Inc's market cap, and Banco Santander SA pays a 1.89% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | SAN | |
|---|---|---|
Market Cap | $10.63B | $211.63B |
Sector | Technology | Financials |
52-Week High | $87.26 | $14.71 |
52-Week Low | $34.31 | $9.37 |
Enterprise Value | $10.74B | — |
Dividend Yield | — | 1.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →
